MMP9 and colorectal cancer: Here, we report the development of a highly selective and potent allosteric antibody inhibitor of MMP9: we show that inhibition of MMP9 is efficacious in mouse models of UC and colorectal cancer, and that this therapy does not induce MSS in a rat model.